Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Vanadis Core T21/T18/T13 Reagent Cartridge
Vanadis Core T21/T18/T13 Reagent Cartridge
Vanadis Core® qualitative assay for screening the risk of trisomy 21, 18, and/or 13.
Products may not be licensed in accordance with the laws in all countries, such as the United States. Please check with your local representative for availability.
| Feature | Specification |
|---|---|
| Application | Noninvasive Prenatal Testing (NIPT) |
Vanadis Core® qualitative assay for screening the risk of trisomy 21, 18, and/or 13.
Products may not be licensed in accordance with the laws in all countries, such as the United States. Please check with your local representative for availability.
Vanadis Core T21/T18/T13 Reagent Cartridge
Vanadis Core T21/T18/T13 Reagent Cartridge
Product information
Overview
Qualitative assay intended for an in vitro diagnostic use to act as an aid in screening for the risk of trisomy 21, 18, and/or 13 in fetus using cell-free DNA from pregnant women of at least 10 weeks of gestation.
Specifications
| Application |
Noninvasive Prenatal Testing (NIPT)
|
|---|---|
| Brand |
Vanadis Core®
|
| Disorders |
Common Trisomies
|
| Instrument Compatibility |
Vanadis NIPT System
|
| Sample Type |
Serum
|
| Technology |
Rolling Circle Amplification (RCA)
|
| Unit Size |
84 samples
|
Resources
Are you looking for resources, click on the resource type to explore further.
How can we help you?
We are here to answer your questions.
